Tag: index

TORONTO, 19 juin 2026 (GLOBE NEWSWIRE) -- Gestion d’actifs BlackRock Canada Limitée (« BlackRock Canada »), filiale indirecte en propriété exclusive de BlackRock, Inc. (« BlackRock ») (NYSE : BLK), a annoncé aujourd’hui avoir mis à jour les niveaux de risque de placement des FNB iShares énumérés ci-après, avec prise d’effet en date du 19 juin 2026 :

AI‑Powered Automated BTC Strategy Contracts help users capture volatility‑driven opportunities instantly—no installation, no manual trading, no experience required.

EBENE CYBERCITY, Mauritius, June 19, 2026 (GLOBE NEWSWIRE) -- IUX has released an educational analysis examining how periods of heightened economic volatility, particularly following major macroeconomic announcements, may influence Force Sell risk in leveraged trading. The publication comes as recent economic data releases have once again highlighted the impact that unexpected market movements can have on leveraged positions when outcomes diverge significantly from market expectations.

WHEATON, Ill., June 18, 2026 (GLOBE NEWSWIRE) -- Innovator Capital Management, LLC (“Innovator”), the investment adviser for the Innovator Gradient Tactical Rotation Strategy ETF and Innovator Hedged Nasdaq-100 ETF (each, a “Fund” and collectively, the “Funds”), announced today that the Funds’ Board of Trustees, at the recommendation of Innovator, has approved a plan of liquidation for each Fund (collectively, the “Plans”). Under the Plans, which are effective as of June 17, 2026, the Funds will begin the process of liquidating portfolio assets and unwinding their affairs in an orderly fashion over time. The Plans are not subject to shareholder approval.

PRESS
RELEASE

MANCHESTER, United Kingdom and OSAKA, Japan, June 18, 2026 (GLOBE NEWSWIRE) -- F2G Ltd and Shionogi & Co., Ltd (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D) (“Shionogi”) today announced positive topline results from the global Phase 3 OASIS study (NCT05101187), comparing the investigational oral antifungal drug olorofim versus AmBisome® (liposomal amphotericin B for injection) followed by standard of care (SOC) in patients with invasive aspergillosis whose infection is either refractory to or unsuitable for azole therapy.

TAMPA, Fla., June 17, 2026 (GLOBE NEWSWIRE) -- HCI Group, Inc. (NYSE: HCI) today announced the launch of a pilot project featuring digital tokenized reinsurance securities offering contractual returns that mirror the performance of specific participations by its Cayman Islands-based reinsurance subsidiary, Fortex Reinsurance SPC, Ltd. ("Fortex Re"), in HCI's catastrophe excess-of-loss reinsurance programs. HCI is launching this pilot project to explore new ways to expand investor access to catastrophe risk as an asset class.